Colour Changing Contact Lenses In Development For Diabetics To Replace The Need To Routinely Draw Blood Throughout The Day
Diabetics may soon be able to wear contact lenses that continuously alert them to variations in their glucose levels by changing coloursreplacing the need to routinely draw blood throughout the day.
The non-invasive technology, developed by Chemical and Biochemical Engineering professor Jin Zhang at The University of Western Ontario, uses extremely small nanoparticles embedded into the hydrogel lenses. These engineered nanoparticles react with glucose molecules found in tears, causing a chemical reaction that changes their colour.
Zhang received $216,342 from the Canada Foundation for Innovation (CFI) this morning to further develop technologies using multifunctional nanocomposites.
These technologies have vast potential applications beyond biomedical devices, including for food packaging. For example, nanocomposite films can prevent food spoilage by preventing oxygen, carbon dioxide and moisture from reaching fresh meats and other foods, or by measuring pathogenic contamination; others can make packaging increasingly biodegradable.
Overall, Western was awarded $2,659,595 for 12 projects from the CFI’s Leaders Opportunity Fund today.
For more information, please visit: http://www.innovation.ca/en/news?news_id=214
Source:
Douglas Keddy
University of Western Ontario
source : www.medicalnewstoday.com
Related News:
- What’s Causing Life-Threatening Blood Clots Following Brain Surgery?
- New Evidence That Fat Cells Are Not Just Dormant Storage Depots For Calories
- Some African-Americans With Chronic Kidney Disease Benefit From Lower Blood Pressure Goal
- Bone Hormone Levels Linked To Risk Of Death For Patients With Heart Failure
- Rare Kidney Disease Caused By Genetic Copy Number Variation
- Common Blood Cell Variations Not An Independent Predictor Of Adverse Outcomes For European Kidney Disease Patients
- Medicine Reaches The Target With The Help Of Magnets
- Insulin Resistance, Type 2 Diabetes Linked To Plaques Associated With Alzheimer’s Disease
- Two-Year Data From Phase 2 Trial Of Genzyme’s Eliglustat Tartrate For Gaucher Disease To Be Published In The Journal Blood
- Dilation Of Blood Vessels Restores Muscle Synthesis In Elderly
Details :
Submited at Tuesday, December 29th, 2009 at 7:00 am on Ophthalmology by robert
Comment RSS 2.0 - leave a comment - trackback
















